Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Gyre Therapeutics, Inc.

NASDAQ: GYRE · Life Sciences · 3 alerts · CIK 1124105

Share price
$4.39Close, Nov 16
Market cap
$506M
Shares outstanding
115.32MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Gyre Therapeutics, Inc. filings on SEC EDGAR ↗

4:02 PM ET 8-K
Executive Compensation

Gyre Therapeutics Executive Compensation

Gyre Therapeutics entered into new employment agreements with CEO Ying Luo, Ph.D., and CFO Thomas Eastling to continue their service. The agreements establish annual base salaries of $500,000 and $339,066 respectively, along with target bonuses and severance provisions including salary continuation and accelerated equity vesting upon certain termination events.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.